QP3-RT 10mg
Investigational triple receptor agonist for metabolic research.
This 10 mg vial is the entry size of QP3-RT, an investigational triple agonist of two incretin receptors and the glucagon receptor. It suits preliminary experiments, receptor-binding screens and method development before a laboratory commits to a larger stock.
QP3-RT is a 39-residue peptide built on an incretin-style backbone, with non-natural amino acid substitutions that protect it from enzymatic cleavage and a lipid side chain that supports albumin binding. In receptor pharmacology the key question is relative potency: how strongly the molecule signals at each of its three targets, and how that ratio translates into cAMP responses in cell lines that express one receptor or several. Metabolic research uses it alongside single and dual agonists to separate the contribution of glucagon-receptor activity from incretin effects.
This vial has a third-party certificate of analysis (batch COA #10445, 99.88% by RP-HPLC, issued by Bioviridian Inc.). For laboratory research use only.
Research areas: Receptor potency profiling, cAMP signaling assays, Incretin and glucagon receptor research, Metabolic pathway studies.
Category: Metabolic. Price: $45.00 USD. 99.88% HPLC purity (third-party lab tested, batch COA #10445: https://orderqualitypeptides.com/coa/COA10445.pdf).
All products are sold strictly for in-vitro laboratory research. Not for human or veterinary use. Not drugs or supplements.